Osteoporosis medication use among Australian women over two decades
Amanda L Stuart, Julie A Pasco, Mohammadreza Mohebbi, Mark A Kotowicz, Kara L Holloway-Kew, Sarah M Hosking, Lana J Williams
Archives of Osteoporosis | SPRINGER LONDON LTD | Published : 2020
Despite the burden of osteoporosis and treatment availability, a treatment gap remains. Women in a population-based study were followed with respect to use of anti-fracture medication over two decades. Use increased over time but remained suboptimal, with less than 20% of those at high risk of fracture receiving treatment. PURPOSE: We examined trends in osteoporosis-related medication use over time using data from the Geelong Osteoporosis Study, an ongoing, population-based study. METHODS: Self-reported medication use data were available for 822 women (50-90 years) at time-1 (1993-1997), 575 women at time-2 (2004-2008), and 527 women at time-3 (2011-2014) participating in a longitudinal stud..View full abstract
Awarded by National Health andMedical Research Council of Australia
Awarded by NHMRC Career Development Fellowship
The Geelong Osteoporosis Study (GOS) is financially supported by the National Health andMedical Research Council of Australia (projects 299831, 628582, 1009367, 1026265, 1021345, 1104438). KLH-K is financially supported by an Alfred Deakin Postdoctoral Research Fellowship. SMH is financially supported by a Deakin University Dean's Research Postdoctoral Fellowship. LJW is financially supported by a NHMRC Career Development Fellowship (1064272).